TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Stem Cell Therapy Market, by Type
6.1 Introduction
6.2 Allogeneic
6.3 Autologous
Chapter 7. Global Stem Cell Therapy Market, by Therapeutic Application
7.1 Introduction
7.2 Medicine
7.3 Cardiovascular Diseases
7.4 Bone Regeneration
7.5 Neurodegenerative Disorders
7.6 Wound Healing
7.7 Treatment of Eyes
7.8 Hematopoietic Disorders
7.9 Metabolic Disorders
7.10 Cancer
7.11 Immunodeficiency
7.12 Diabetes
Chapter 8. Global Stem Cell Therapy Market, by Cell source
8.1 Introduction
8.2 Adipose tissue
8.3 Bone Marrow
8.3 Neural
8.4 Embryo/Cord Blood-Derived
8.5 iPSCs
Chapter 9. Global Stem Cell Therapy Market, by End -User
9.1 Introduction
9.2 Biotechnology Companies
9.3 Hospitals & Research Institutes
9.4 Contract Research Organizations
9.5 Stem cell banks
Chapter 10. Global Stem Cell Therapy Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Osiris Therapeutics, Inc.
12.1.1 Company Overview
12.1.2 Product Type Overview
12.1.3 Financials
12.2.4 Key Developments
12.1.5 SWOT Analysis
12.2 MEDIPOST Co., Ltd.
12.2.1 Company Overview
12.2.2 Product Type Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Anterogen Co., Ltd.
12.3.1 Company Overview
12.3.2 Product Type Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Pharmicell Co., Ltd.
12.4.1 Company Overview
12.4.2 Product Type/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Holostem Terapie Avanzate S.r.l.
12.5.1 Company Overview
12.5.2 Product Type Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 JCR Pharmaceuticals Co., Ltd.
12.6.1 Company Overview
12.6.2 Product Type Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 NUVASIVE, INC
12.7.1 Overview
12.7.2 Product Type Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 RTI Surgical, Inc.
12.8.1 Overview
12.8.2 Product Type Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 AlloSource
12.9.1 Overview
12.9.2 Product Type Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Thermo Fisher Scientific
12.10.1 Overview
12.10.2 Product Type Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Others
Chapter 14 Appendix
LIST OF TABLES
Table 1 Stem Cell Therapy Market Industry Synopsis, 2023-2030
Table 2 Global Stem Cell Therapy Market Estimates & Forecast, 2023-2030, (USD Million)
Table 3 Global Stem Cell Therapy Market, by Region, 2023-2030, (USD Million)
Table 4 Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 5 Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 7 Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 8 Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million
Table 9 North America: Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 10 North America: Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 12 North America: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 13 North America: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million)
Table 14 US: Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 15 US: Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 17 US: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 18 US: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million)
Table 19 Canada: Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 20 Canada: Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 22 Canada: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 23 Canada: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million)
Table 24 South America: Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 25 South America: Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 27 South America: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 28 South America: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million)
Table 29 Europe: Global Stem Cell Therapy Market, Type, 2023-2030, (USD Million)
Table 30 Europe: Global Stem Cell Therapy Market, Therapeutic Application, 2023-2030, (USD Million)
Table 32 Europe: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 33 Europe: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million)
Table 34 Western Europe: Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 35 Western Europe: Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 37 Western Europe: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 38 Western Europe: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million
Table 39 Eastern Europe: Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 40 Eastern Europe: Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 42 Eastern Europe: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 43 Eastern Europe: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million)
Table 44 Asia-Pacific: Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 45 Asia-Pacific: Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 47 Asia-Pacific: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 48 Asia-Pacific: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million)
Table 49 Middle East & Africa: Global Stem Cell Therapy Market, by Type, 2023-2030, (USD Million)
Table 50 Middle East & Africa: Global Stem Cell Therapy Market, by Therapeutic Application, 2023-2030, (USD Million)
Table 52 Middle East & Africa: Global Stem Cell Therapy Market, by Cell Source, 2023-2030, (USD Million)
Table 53 Middle East & Africa: Global Stem Cell Therapy Market, by End-User, 2023-2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for the Global Stem Cell Therapy Market
Figure 3 Market Dynamics for Global Stem Cell Therapy Market
Figure 4 Global Stem Cell Therapy Market Share, by Type 2020
Figure 4 Global Stem Cell Therapy Market Share, by Product Type 2020
Figure 5 Global Stem Cell Therapy Market Share, by Cell Source 2020
Figure 6 Global Stem Cell Therapy Market Share, by End-User, 2020
Figure 7 Global Stem Cell Therapy Market Share, by Region, 2020
Figure 8 North America Stem Cell Therapy Market Share, by Country, 2020
Figure 9 Europe Stem Cell Therapy Market Share, by Country, 2020
Figure 10 Asia-Pacific Stem Cell Therapy Market Share, by Country, 2020
Figure 11 Middle East & Africa Stem Cell Therapy Market Share, by Country, 2020
Figure 12 Global Stem Cell Therapy Market: Company Share Analysis, 2020 (%)
Figure 13 Osiris Therapeutics, Inc.: Key Financials
Figure 14 Osiris Therapeutics, Inc.: Segmental Revenue
Figure 15 Osiris Therapeutics, Inc.: Geographical Revenue
Figure 16 MEDIPOST Co., Ltd.: Key Financials
Figure 17 MEDIPOST Co., Ltd.: Segmental Revenue
Figure 18 MEDIPOST Co., Ltd.: Geographical Revenue
Figure 19 Anterogen Co., Ltd.: Key Financials
Figure 20 Anterogen Co., Ltd.: Segmental Revenue
Figure 21 Anterogen Co., Ltd.: Geographical Revenue
Figure 22 Pharmicell Co., Ltd.: Key Financials
Figure 23 Pharmicell Co., Ltd.: Segmental Revenue
Figure 24 Pharmicell Co., Ltd.: Geographical Revenue
Figure 25 JCR Pharmaceuticals Co., Ltd.: Key Financials
Figure 26 JCR Pharmaceuticals Co., Ltd.: Segmental Revenue
Figure 27 JCR Pharmaceuticals Co., Ltd.: Geographical Revenue
Figure 28 Holostem Terapie Avanzate S.r.l.: Key Financials
Figure 29 Holostem Terapie Avanzate S.r.l. : Segmental Revenue
Figure 30 Holostem Terapie Avanzate S.r.l.: Geographical Revenue
Figure 31 NUVASIVE, INC: Key Financials
Figure 32 NUVASIVE, INC: Segmental Revenue
Figure 33 NUVASIVE, INC: Geographical Revenue
Figure 34 RTI Surgical, Inc.: Key Financials
Figure 35 RTI Surgical, Inc.: Segmental Revenue
Figure 36 RTI Surgical, Inc.: Geographical Revenue
Figure 37 AlloSource: Key Financials
Figure 38 AlloSource: Segmental Revenue
Figure 39 AlloSource: Geographical Revenue
Figure 40 Thermo Fisher Scientific: Key Financials
Figure 41 Thermo Fisher Scientific: Segmental Revenue
Figure 42 Thermo Fisher Scientific: Geographical Revenue
